Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome

Published:2014-03 Issue:9 Volume:63 Page:872-877
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Bonello Laurent,Laine Marc,Kipson Nathalie,Mancini Julien,Helal Olfa,Fromonot Julien,Gariboldi Vlad,Condo Jocelyne,Thuny Franck,Frere Corinne,Camoin-Jau Laurence,Paganelli Franck,Dignat-George Françoise,Guieu Regis

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (Platelet Inhibition and Patient Outcomes) PLATELET substudy;Storey;J Am Coll Cardiol,2010

2. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

3. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study;Mehta;Lancet,2001

4. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

5. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26;Eltzschig;Blood,2006

Cited by 253 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Ticagrelor with Clopidogrel on Coronary Microvascular Dysfunction Following Acute Myocardial Infarction Using Angiography-Derived Index of Microcirculatory Resistance;Cardiovascular Drugs and Therapy;2024-09-02

2. An interesting case series of ticagrelor induced long QTc;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09

3. Ticagrelor potentiates cardioprotection by remote ischemic preconditioning: the ticagrelor in remote ischemic preconditioning (TRIP) randomized clinical trial;Hellenic Journal of Cardiology;2024-06

4. Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease;Nutrients;2024-03-22

5. Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach;Journal of Cardiovascular Pharmacology;2024-02-05